Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Vaccines Summit 2019

About Conference


Vaccines Conferences Committee looks forward to welcome all the participants across the world to attend "32nd International Conference on Vaccines and Immunization" during March 21-22, 2019 in Rome, Italy. 

Vaccines Summit 2019 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination, Immunization and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Immunization or its sister publication, Journal of Clinical & Cellular Immunology and Immunome Research. Conference Series llc LTD organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccines Summit 2019 is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Immunology and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Immunology community. It provide an explicit platform for presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Target Audience:

  • Researchers & Scientists related to Vaccine R&D
  • Deans and Professors
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators

 

Session Tracks

Track 1: Bacterial and Viral Vaccines:

Vaccination can be defined as active immunity produced by vaccine. It is immunity and immunologic memory similar to natural infection but without risk of disease. There are two basic types of vaccines: live attenuated and inactivated. Live attenuated vaccines are produced by modifying a disease-producing virus or bacterium in a laboratory. Vaccines derived from bacterium are called as bacterial vaccine and from virus is as viral vaccine. The resulting vaccine organism retains the ability to replicate and produce immunity, but usually does not cause illness. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries llc Ltd

Food Microbiology Conferences, November 29-30,2018 Dublin, Ireland; Natural Products, Medicinal Plants & Marine Drugs Conferences, June 11-12, 2018 Rome, Italy; Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain;

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 2: Vaccines against infectious diseases:

Vaccination is the administration of agent-specific, but relatively harmless, antigenic components that in vaccinated individuals can induce protective immunity against the corresponding infectious agent. In practice, the terms “vaccination” and “immunization” are often used interchangeably. Vaccination is a highly effective method of preventing certain infectious diseases. Vaccines are generally very safe and serious adverse reactions are uncommon. Routine immunization programmes protect most of the world’s children from a number of infectious diseases that previously claimed millions of lives each year.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | Conference Series llc Ltd

Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 3: Cancer Vaccines:

Cancer is the name given for these diseases in which the body cells become abnormal and divide without control. Cancer cells may invade nearby tissues. And they may spread through the bloodstream and lymphatic system to other parts of the body. The aim of cancer vaccines is to stimulate the immune system to be able to recognise cancer cells as abnormal and destroy them. Some vaccines for particular cancers have been developed and are being tested to see whether they can treat a cancer, or help to stop it from coming back after cancer treatment. There are two major categories that cancer vaccines fit into: Specific cancer vaccine & Universal cancer vaccine. As the name suggests, specific cancer vaccines are designed to treat specific types of cancers. In other words, a vaccine could be developed for lung cancer, another vaccine could be used to treat colon cancer and yet another vaccine could treat skin cancer and so on. A more appealing cancer vaccine would be one that could fight cancer cells regardless of cancer type. This type of vaccine is called a universal cancer vaccine. Different types of cancer vaccines being developed these days are: Antigen vaccines, Anti-idiotype vaccines, Dendritic cell vaccines, Tumor cell vaccines, DNA vaccines.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl; Midwifery & Womens Health Conferences, October 01-02, 2018 Frankfurt, Germany; Gynecology and Obstetrics Conferences, October 08-10, 2018 Zurich, Switzerland
 

 

 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 4: DNA, Protein and Toxoid Vaccines:

Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based. Protein-based vaccines include toxoids (inactivated bacterial toxin) and subunit or subvirion products. When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain;

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 5: Combination and Conjugate Vaccines:

Combination vaccines take two or more vaccines that could be given individually and put them into one shot. Children get the same protection as they do from individual vaccines given separately—but with fewer shots. The use of combination vaccines improves timely vaccination coverage, according to several studies. Conjugate polysaccharide vaccines are those in which the polysaccharide is chemically linked to a protein. This linkage makes the polysaccharide a more potent vaccine. Polysaccharide coatings disguise a bacterium’s antigens so that the immature immune systems of infants and younger children can’t recognize or respond to them. Conjugate vaccines, a special type of subunit vaccine, get around this problem. When making a conjugate vaccine, antigens or toxoids from a microbe that an infant’s immune system can recognize to the polysaccharides are linked. The linkage helps the immature immune system react to polysaccharide coatings and defend against the disease-causing bacterium.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain;

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 6: Travel and edible Vaccines:

Travel vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travellers and to prevent disease spread within and between countries. There is no single vaccination schedule that fits all travellers. Each schedule must be individualized according to the traveller’s previous immunization, health status and risk factors, the countries to be visited, the type and duration of travel, and the amount of time available before departure. Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 7: Malaria and TB Vaccines :

Malaria continues to claim an estimated 2 to 3 million lives annually and to account for untold morbidity in the approximately 300 to 500 million people infected annually. Malaria is considered a re-emerging disease, due largely to the spread of drug-resistant parasite strains, decay of health-care infrastructure and difficulties in implementing and maintaining vector control programs in many developing countries. Four species of protozoan parasites cause malaria in humans: Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. P. falciparum is responsible for the majority of deaths and most of the severe forms of disease, including cerebral malaria. 2 billion people latently infected with M. tuberculosis 5-10% infected people progress to disease 9 million new TB cases each year 1.5 million TB deaths each year Equivalent to 20 passenger aircraft crashes each day. TB is transmitted by adults with cavitatory disease HIV infected people carry greater burden of disease. Highest risk of progression from TB infection to active disease, and worst TB morbidity and mortality, compared to older children and adults.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Natural Products, Medicinal Plants & Marine Drugs Conferences, June 11-12, 2018 Rome, Italy; Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 8: Hepatitis, HIV and STD Vaccines:

The term 'hepatitis' means inflammation of the liver. Hepatitis can be caused by viruses, other infectious agents, alcohol, and other chemicals. The two viruses that most commonly infect the liver are the hepatitis A virus and the hepatitis B virus. Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. Hepatitis B vaccine is available for all age groups to prevent HBV infection.

The most important breakthroughs of the past century involved the development of vaccines to protect against viruses: smallpox, polio, hepatitis, human papillomavirus (HPV), and even chickenpox. But one virus remains elusive to those seeking to create a vaccine to guard against it: HIV. Getting vaccinated early, before sexual exposure, is also effective in preventing certain types of STIs. Vaccines are available to prevent human papillomavirus (HPV), hepatitis A and hepatitis B. 

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 9: Paediatric Vaccination:

Immunization against diseases such as polio, tetanus, diphtheria, and pertussis saves the lives of approximately three million people each year. Immunization also prevents many more millions from suffering debilitating illness and lifelong disability. Globally, approximately 132 million babies need to be fully immunized each year. In order to meet this need, immunization systems must have adequate resources, trained and motivated staff, and ample vaccine and syringe supplies.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Food Microbiology Conferences, November 29-30,2018 Dublin, Ireland; Natural Products, Medicinal Plants & Marine Drugs Conferences, June 11-12, 2018 Rome, Italy; Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 10: Vaccines for Immune mediated diseases:

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes current literature data on vaccine safety and efficacy in IMID patients treated with immunosuppressive or immunomodulatory drugs and formulates best-practice recommendations on vaccination in this population. Especially in the current era of biological therapies, including TNF-blocking agents, special consideration should be given to vaccination strategies in IMID patients. Clinical evidence indicates that immunization of IMID patients does not increase clinical parameters of disease activity. Live vaccines are contraindicated in immunocompromized individuals, but non-live vaccines can safely be given. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for hepatitis B, influenza and pneumococcal vaccination. Vaccination status is best checked and updated before the start of immunomodulatory therapy: live vaccines are not contraindicated at that time and inactivated vaccines elicit an optimal immune response in immunocompetent individuals.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl; Midwifery & Womens Health Conferences, October 01-02, 2018 Frankfurt, Germany; Gynecology and Obstetrics Conferences, October 08-10, 2018 Zurich, Switzerland

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 11: Vaccination for Emerging and Re-emerging diseases:

An emerging infectious disease (EID) is an infectious disease whose incidence has increased in the past 20 years and could increase in the near future. Emerging infections account for at least 12% of all human pathogens. And Re-emerging infectious diseases are diseases that once were major health problems globally or in a particular country, and then declined dramatically, but are again becoming health problems for a significant proportion of the population.

Ebola virus, Marburg virus, Lassa fever, Hantavirus, yellow fever and dengue fever are all highly infectious and lead to a potentially fatal disease with fever, malaise, vomiting, mucosal and gastrointestinal bleeding, oedema, and hypotension.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 12: Vaccine production and delivery technologies:

Vaccine production has several stages. First, the antigen itself is generated. Viruses are grown either on primary cells such as chicken eggs (e.g., for influenza) or on continuous cell lines such as cultured human cells (e.g., for hepatitis A). Bacteria are grown in bioreactors (e.g., Haemophilus influenzae type b).

There is currently intense research activity aimed at the development of new delivery systems for vaccines. The goal is to identify optimal methods for presenting target antigens to the immune system in a manner that will elicit immune responses appropriate for protection against, or treatment of, a specific disease. Several different approaches to this general goal have been developed, some are empirical and remain poorly understood, others are more rational, being based, for example, on mimicking natural infections in vivo or on targeting particular features of the immune system.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain.

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 13: Vaccine Safety and Efficacy:

The safety and effectiveness of vaccines are under constant study. Because vaccines are designed to be given routinely during well-child care visits, they must be extraordinarily safe. Safety testing begins as soon as a new vaccine is contemplated, continues until it is approved by the FDA, and is monitored indefinitely after licensure. The American Academy of Pediatrics (AAP) works closely with the Centers for Disease Control and Prevention (CDC) to make recommendations for vaccine use.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 14: Vaccines Industry and Manufacturing:

2 important topics of current good manufacturing practices as they apply to vaccine products: product inspections and stability testing. The perspective presented is that of regulated industry. There are 2 major categories of product/facility inspections: those occurring before licensure of a vaccine product and those occurring after a vaccine product is licensed. The logistics and focus of each inspection type, the preapproval inspection, and the required biennial inspection are discussed, as are guidance and recommendations for achieving successful inspections. The requirements, guidance, and recommendations regarding the type, amount, and extensiveness of stability data for vaccine products are presented. The discussion details the potential differences in the amount and type of data required for products that are not yet licensed versus marketed products. 

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl; Midwifery & Womens Health Conferences, October 01-02, 2018 Frankfurt, Germany; Gynecology and Obstetrics Conferences, October 08-10, 2018 Zurich, Switzerland;

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 15: Geriatric Immunization:

Many adults feel that they do not need vaccinations, or worry about side effects from the vaccine itself, but people age 65 and older are at higher risk of complications from the actual diseases. It is important for older adults to keep vaccines current: they may not have been vaccinated as a child, new vaccinations may now be available, immunity may have faded, and most importantly, seniors are more susceptible to serious and possibly life-threatening infections. The most important vaccinations seniors should discuss with their physicians include the flu vaccine, pneumococcal vaccine to prevent pneumonia, shingles vaccine, and a tetanus-diptheria-pertussis vaccine (Tdap).

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 16: Vaccines for unconventional diseases:

When vaccines are mentioned most people think of immunization against childhood infectious diseases. However, in recent years the uses to which vaccines are being put has dramatically expanded beyond traditional infectious disease applications. Vaccines currently in preclinical and clinical development target prevention or treatment of a wide range of non-infectious diseases including cancer, allergy, asthma, diabetes, rheumatoid arthritis, lupus, hypertension, heart disease, obesity, Alzheimer’s disease, Parkison’s disease and even nicotine and cocaine addiction. For the most part such vaccines aim to induce neutralizing antibodies against foreign or self-antigens, thereby blocking their activity and ability to induce disease. This commentary reviews key clinical advances in the area of unconventional vaccines and identifies some of the key challenges that need to be overcome in order for unconventional vaccines to move forward to medical and commercial success.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 17: Animal and Plant Derived Vaccines:

Many of the main advances in Immunology have arisen as a result of the use of animals. The development of transplantation surgery and the development of new medicines and vaccines would not be possible without animal research. The use of animal models has helped us understand how infectious diseases occur. This has led scientists to develop preventative treatments in the form of vaccines to help reduce the likelihood of someone being infected with a dangerous microbe, such as those responsible for causing polio, diphtheria, and hepatitis C. 

Transgenic plants have been identified as promising expression systems for vaccine production. Complex plants such as tobacco, potato, tomato, and banana can have genes inserted that cause them to produce vaccines usable for humans. Bananas have been developed that produce a human vaccine against Hepatitis B. Another example is the expression of a fusion protein in alfalfa transgenic plants for the selective directioning to antigen presenting cells, therefore increasing vaccine potency against Bovine Viral Diarrhea Virus (BVDV).

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 18: Vaccines for pregnant women and Neonates:

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. CDC has guidelines for the vaccines you need before, during, and after pregnancy. Some vaccines, such as the measlesmumps, rubella (MMR) vaccine, should be given a month or more before pregnancy. You should get some vaccines, like Tdap (to protect against whooping cough), during your pregnancy. The Advisory Committee on Immunization Practices (ACIP) recommends that all children receive their first dose of Hepatitis B vaccine at birth and complete the vaccine series by age 6–18 months. Older children and adolescents who did not previously receive the Hepatitis B vaccine should also be vaccinated.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain; Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 19: Animal Models and Clinical Trails:

Mouse models of human cancer have played a vital role in understanding tumorigenesis and answering experimental questions that other systems cannot address. Advances continue to be made that allow better understanding of the mechanisms of tumor development, and therefore the identification of better therapeutic and diagnostic strategies. We review major advances that have been made in modeling cancer in the mouse and specific areas of research that have been explored with mouse models.

Clinical trials are research studies intended to answer scientific questions and find better ways to treat or prevent diseases. They are fundamental to the development of innovative medicines, vaccines or devices that treat and prevent illness. 

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 20: Cellular Immunology and Latest Innovations:

The response to pathogens is composed by the complex interactions and activities of the large number of diverse cell types involved in the immune response. The innate immune response is the first line of defense and occurs soon after pathogen exposure. It is carried out by phagocytic cells such as neutrophils and macrophages, cytotoxic natural killer (NK) cells, and granulocytes. The subsequent adaptive immune response includes antigen-specific defense mechanisms and may take days to develop. Cell types with critical roles in adaptive immunity are antigen-presenting cells including macrophages and dendritic cells. Antigen-dependent stimulation of various cell types including T cell subsets, B cells, and macrophages all play critical roles in host defense.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK; Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl; Midwifery & Womens Health Conferences, October 01-02, 2018 Frankfurt, Germany; Gynecology and Obstetrics Conferences, October 08-10, 2018 Zurich, Switzerland;

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 21: Clinical Immunology & Cancer Immunotherapy:

Clinical immunology is the study of diseases caused by disorders of the immune system (failure, aberrant action, and malignant growth of the cellular elements of the system). It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features.

The diseases caused by disorders of the immune system fall into two broad categories:

Immunodeficiency, in which parts of the immune system fail to provide an adequate response (examples include chronic granulomatous disease and primary immune diseases);

Autoimmunity, in which the immune system attacks its own host's body (examples include systemic lupus erythematosus, rhematoid arthritis, Hashimoto's disease and myasthenia gravis). 

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Medicinal Plants & Marine Drugs Conferences, June 11-12, 2018 Rome, Italy; Antibody Engineering Conferences, June 14-16 , 2018 Rome, Italy; Vascular Dementia Conferences, July 23-25, 2018 Moscow, Russia; Food Processing & Analysis Conferences, October 11-13, 2018 Moscow, Russia; Allergy, Asthma & Clinical Immunology Conferences, October 1-2, 2018 Moscow, Russia; Infection Prevention and Control Conferences, October 11-12, 2018 Moscow, Russia; Antibiotics and Antibiotic Resistance Conferences, June 14-15, 2018 Barcelona, Spain; Food Safety and Regulatory Measures Conferences, June 11-12, 2018 Barcelona, Spain; Medicinal Food Microbiology Conferences, November 29-30,2018 Dublin, Ireland; Natural Products, Chemistry and Drug Design Conferences, June 14-15, 2018 Barcelona, Spain

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 22: Molecular and Structural Immunology:

Molecular Immunology is primarily devoted to publications concerned with immunological knowledge at the molecular, cellular and functional levels of innate and acquired immunity, including but not limited to: molecular mechanisms of innate and adaptive immunity phenomena, molecular aspects of immune regulation and immunogenomics, immunoproteomics and immunoglycomics.

Structural genomics seeks to describe the 3-dimensional structure of every protein encoded by a given genome. This genome-based approach allows for a high-throughput method of structure determination by a combination of experimental and modeling approaches.

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Vaccines & Vaccination Conferences, June 14-16, 2018 Barcelona, Spain; Advances in Chromatography & HPLC Techniques Conferences, August 02-03, 2018 Barcelona, Spain; Clinical and Cellular Immunology Conferences, August 6-7, 2018 Madrid, Spain; Pediatrics Health Conferences, August 06-07, 2018 Madrid, Spain; Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; General Practice & Primary Care Conferences, August 16-17, 2018 Madrid, Spain; Advanced Nursing Research Conferences, June 14-15, 2018 Dublin, Ireland; Patient Safety & Quality Healthcare Conferences, June 21-22, 2018 Dublin, Ireland; Cancer Nursing & Nurse Practitioners Conference Conferences, July 16-17, 2018 London, UK

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 23: Antibodies: Engineering and Therapeutics:

Antibody Genetic Engineering & Therapeutics meeting brought together a broad range of participants who were updated on the latest advances in antibody research and development. Organized by IBC Life Sciences, the gathering is the annual meeting of The Antibody Society, which serves as the scientific sponsor. Preconference workshops on 3D modeling and delineation of clonal lineages were featured. The conference included sessions on a wide variety of topics relevant to researchers, including systems biology; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates. 

Related: Vaccines Conferences World Vaccine Congress | Immunology Conferences | ConferenceSeries Ltd:

Men in Nursing Conferences, July 16-17, 2018 Rome, Italy;Emergency Nursing & Critical Care Conferences, July 16-17, 2018 London, UK;  Pediatric Nursing & Healthcare Conferences, August 16-17, 2018 Madrid, Spain; Clinical Nursing and Practice Conferences, August 29-30, 2018 Zurich, Switzerlandl; Midwifery & Womens Health Conferences, October 01-02, 2018 Frankfurt, Germany; Gynecology and Obstetrics Conferences, October 08-10, 2018 Zurich, Switzerland

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

 

Past Conference Report

Vaccines Summit 2018

The 29th International Conference on Vaccines and Immunization (Vaccines Summit 2018) hosted by Conference Series LLC Ltd took place at London, UK during March 19-20, 2018. It was organized by Conference Series LLC Ltd and generous response was received from the Editorial Board Members of Conference Series LLC Ltd Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from Conference Series LLC Ltd. The two day program witnessed thought provoking Keynote and Plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme, Highlights of latest technologies and innovations in Vaccines and Immunization".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Human Vaccines against Infectious Diseases
  • Cancer, Malaria & TB Vaccines
  • HIV Vaccines
  • Immunizations & Bioterrorism
  • Combination & Conjugate Vaccines
  • DNA & Synthetic Vaccines
  • Travel & Edible Vaccines
  • Paediatric Vaccination
  • Vaccines for Immune Mediated Diseases
  • Veterinary Vaccines
  • Fish & Poultry Vaccines
  • Vaccines against Drugs‎
  • Vaccines & Autism
  • Vaccine Safety & Efficacy
  • Geriatric Immunization
  • Vaccines for Pregnant Women & Neonates
  • Vaccines for Unconventional Diseases
  • Animal Models & Clinical Trials
  • Animal & Plant Derived Vaccines
  • Vectors, Adjuvants & Delivery Systems
  • Vaccine Production & Development
  • Cellular Immunology & Latest Innovations
  • Antibodies: Engineering & Therapeutics
  • Current Research & Future Challenges

The highlights of the meeting were the keynote lectures from

  • Pierre A. MORGON , MRGN Advisors, Switzerland
  • Poupak Fallahi, University of Pisa, Italy
  • Silvia Martina Ferrari, University of Pisa, Italy
  • Pramod Jog, Dr. D.Y. Patil Medical College, India
  • Yoshinori HAYAKAWA, Toin University of Yokohama, Japan

Vaccines Summit 2018 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We would specially thank the Moderators Yoshinori HAYAKAWA, Toin University of Yokohama, Japan and Pramod Jog, Dr. D.Y. Patil Medical College, India for their contribution for the conference. We would also like to thank Pierre A. MORGON   , MRGN Advisors, Switzerland and J. Santiago Mejia, Oxford Immunotec, USA for chairing our conference sessions.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines Summit 2018 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC would like to announce the commencement of “32nd International Conference on Vaccines and Immunization during March 21-22, 2019 at Rome, Italy”.

Let us meet again @ Vaccines Summit 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 21-22, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Vaccines & Vaccination Journal of Clinical & Cellular Immunology Immunome Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by